Urothelial cancer
Clinical trials for Urothelial cancer explained in plain language.
Never miss a new study
Get alerted when new Urothelial cancer trials appear
Sign up with your email to follow new studies for Urothelial cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Antibody-Drug conjugate put to the test against Hard-to-Treat cancers
Disease control Not yet recruitingResearchers are running a first-in-human study of MGC030, an antibody-drug conjugate, in people with advanced solid tumors that have come back or stopped responding to standard treatment. The trial includes participants with urothelial, colorectal, gastric, gastroesophageal, esop…
Matched conditions: UROTHELIAL CANCER
Phase 1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can Long-Term tucatinib use remain safe for HER2-Positive cancers?
Disease control Not yet recruitingThis study offers continued access to tucatinib, an oral targeted therapy, for people with HER2-positive cancers (including breast, cervical, and lung) who were already benefiting from the drug in a previous Pfizer-sponsored trial. The main goal is to monitor long-term safety and…
Matched conditions: UROTHELIAL CANCER
Phase 4 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Bladder cancer combo shows promise in Real-World review
Knowledge-focused Not yet recruitingThis study looks back at how well a combination of two drugs—enfortumab vedotin and pembrolizumab—works as the first treatment for people with advanced bladder cancer that has spread. Researchers will collect data from 361 patients around the world to see how long they live and h…
Matched conditions: UROTHELIAL CANCER
Sponsor: Aron Research Foundation Ets • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC